Met. NSCLC

Indication Area All Sessions Resectable NSCLC Metastatic NSCLC SCLC Biomarker Tests & Diagnostics Targeted Therapies Immunotherapies Antibody-Drug Conjugates Talks Related To Metastatic NSCLC AstraZeneca & Daiichi-Sankyo Best Practices in Managing Adverse Events...

Early NSCLC

Indication Area All Sessions Resectable NSCLC Metastatic NSCLC SCLC Biomarker Tests & Diagnostics Targeted Therapies Immunotherapies Antibody-Drug Conjugates Talks Related To Resectable NSCLC MSD Symposium Insights into the treatment of resectable, non-targetable...

All Sessions

Indication Area All Sessions Resectable NSCLC Metastatic NSCLC SCLC Biomarker Tests & Diagnostics Targeted Therapies Immunotherapies Antibody-Drug Conjugates Industry Symposia AstraZeneca & Daiichi-Sankyo Best Practices in Managing Adverse Events with ADCs in...